CHLOE NUZZO: Open Payments
NPI 1477104073 · BALDWINSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 71 payments from 21 companies in 2025. Trend: 2023 $438 · 2024 $1,007 · 2025 $1,617
Food & beverage: $1,617
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $241 |
| Ardelyx, Inc. | 8 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $166 |
| Phathom Pharmaceuticals, Inc. | 3 | $142 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| GlaxoSmithKline, LLC. | 7 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $113 |
| Lilly USA, LLC | 4 | $84 |
| Lundbeck LLC | 3 | $63 |
| Exact Sciences Corporation | 3 | $61 |
Products named: IBSRELA, REXULTI, CAPLYTA, VOQUEZNA, TRELEGY ELLIPTA, Kerendia, FARXIGA, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
